Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 4
1953 2
1954 3
1955 6
1956 10
1957 5
1958 7
1959 5
1960 2
1961 8
1962 7
1963 2
1964 7
1965 25
1966 27
1967 44
1968 47
1969 96
1970 244
1971 295
1972 275
1973 220
1974 213
1975 204
1976 181
1977 135
1978 137
1979 125
1980 111
1981 116
1982 118
1983 132
1984 211
1985 200
1986 268
1987 326
1988 313
1989 377
1990 434
1991 469
1992 561
1993 618
1994 574
1995 688
1996 664
1997 823
1998 895
1999 996
2000 1130
2001 1103
2002 1356
2003 1562
2004 1639
2005 1831
2006 2169
2007 2315
2008 2597
2009 2845
2010 3120
2011 3365
2012 3605
2013 3875
2014 4059
2015 4444
2016 4767
2017 4960
2018 5066
2019 5293
2020 6157
2021 6649
2022 6545
2023 6255
2024 2639

Text availability

Article attribute

Article type

Publication date

Search Results

89,217 results

Results by year

Filters applied: . Clear all
Page 1
Parkinson's Disease.
Reich SG, Savitt JM. Reich SG, et al. Med Clin North Am. 2019 Mar;103(2):337-350. doi: 10.1016/j.mcna.2018.10.014. Epub 2018 Dec 3. Med Clin North Am. 2019. PMID: 30704685 Review.
The diagnosis of Parkinson disease (PD) is based on the presence of bradykinesia and either resting tremor or rigidity and there should be no features from the history or examination to suggest an alternative cause of parkinsonism. In addition to the motor ma …
The diagnosis of Parkinson disease (PD) is based on the presence of bradykinesia and either resting tremor or rigidity …
Parkinson's disease: a review.
Beitz JM. Beitz JM. Front Biosci (Schol Ed). 2014 Jan 1;6(1):65-74. doi: 10.2741/s415. Front Biosci (Schol Ed). 2014. PMID: 24389262 Free article. Review.
Parkinson's Disease is the second most common progressive neurodegenerative disorder affecting older American adults and is predicted to increase in prevalence as the United States population ages. Resulting from a pathophysiologic loss or degeneration of dop
Parkinson's Disease is the second most common progressive neurodegenerative disorder affecting older American adults an
Epidemiology of Parkinson's disease.
Tysnes OB, Storstein A. Tysnes OB, et al. J Neural Transm (Vienna). 2017 Aug;124(8):901-905. doi: 10.1007/s00702-017-1686-y. Epub 2017 Feb 1. J Neural Transm (Vienna). 2017. PMID: 28150045 Review.
Parkinson's disease (PD) affects 1-2 per 1000 of the population at any time. ...Revised diagnostic criteria are expected to improve the clinicians accuracy in diagnosing PD. Increasing knowledge on genetic and environmental risk factors of PD
Parkinson's disease (PD) affects 1-2 per 1000 of the population at any time. ...Revised diagnostic criteria are
Parkinson's Disease in Women and Men: What's the Difference?
Cerri S, Mus L, Blandini F. Cerri S, et al. J Parkinsons Dis. 2019;9(3):501-515. doi: 10.3233/JPD-191683. J Parkinsons Dis. 2019. PMID: 31282427 Free PMC article. Review.
Increasing evidence points to biological sex as an important factor in the development and phenotypical expression of Parkinson's disease (PD). Risk of developing PD is twice as high in men than women, but women have a higher mortality rate and …
Increasing evidence points to biological sex as an important factor in the development and phenotypical expression of Parkinson's
Parkinson's disease: etiopathogenesis and treatment.
Jankovic J, Tan EK. Jankovic J, et al. J Neurol Neurosurg Psychiatry. 2020 Aug;91(8):795-808. doi: 10.1136/jnnp-2019-322338. Epub 2020 Jun 23. J Neurol Neurosurg Psychiatry. 2020. PMID: 32576618 Review.
The concept of 'idiopathic' Parkinson's disease (PD) as a single entity has been challenged with the identification of several clinical subtypes, pathogenic genes and putative causative environmental agents. ...The application of glucagon-like peptide …
The concept of 'idiopathic' Parkinson's disease (PD) as a single entity has been challenged with the identificat …
Exercise and Parkinson's disease.
Xu X, Fu Z, Le W. Xu X, et al. Int Rev Neurobiol. 2019;147:45-74. doi: 10.1016/bs.irn.2019.06.003. Epub 2019 Jun 20. Int Rev Neurobiol. 2019. PMID: 31607362 Review.
Parkinson's disease (PD) is one of the most common neurodegenerative diseases in the world. Unfortunately, most of the currently used clinical therapies against PD are symptomatic and there is still no remedy can stop disease progression.
Parkinson's disease (PD) is one of the most common neurodegenerative diseases in the world. Unfortunately, most
Biomarkers for Parkinson's Disease: Recent Advancement.
Lotankar S, Prabhavalkar KS, Bhatt LK. Lotankar S, et al. Neurosci Bull. 2017 Oct;33(5):585-597. doi: 10.1007/s12264-017-0183-5. Epub 2017 Sep 21. Neurosci Bull. 2017. PMID: 28936761 Free PMC article. Review.
As a multi-factorial degenerative disease, Parkinson's disease (PD) leads to tremor, gait rigidity, and hypokinesia, thus hampering normal living. ...Also, biomarkers, alone or in combination, are used in the diagnosis and evolution of PD
As a multi-factorial degenerative disease, Parkinson's disease (PD) leads to tremor, gait rigidity, and h …
Parkinson's Disease: Risk Factor Modification and Prevention.
Rajan S, Kaas B. Rajan S, et al. Semin Neurol. 2022 Oct;42(5):626-638. doi: 10.1055/s-0042-1758780. Epub 2022 Nov 25. Semin Neurol. 2022. PMID: 36427528 Review.
The global burden of Parkinson's disease (PD) has increased from 2.5 to 6.1 million since the 1990s. ...With the current consensus on the existence of a prediagnostic phase of PD, which can be divided into a preclinical stage and a prodromal sta …
The global burden of Parkinson's disease (PD) has increased from 2.5 to 6.1 million since the 1990s. ...With the …
Autonomic dysfunction in Parkinson's disease: Implications for pathophysiology, diagnosis, and treatment.
Chen Z, Li G, Liu J. Chen Z, et al. Neurobiol Dis. 2020 Feb;134:104700. doi: 10.1016/j.nbd.2019.104700. Epub 2019 Dec 3. Neurobiol Dis. 2020. PMID: 31809788 Free article. Review.
Parkinson's disease (PD) is a neurodegenerative disease with a 200 year-long research history. ...Autonomic dysfunction is an essential category of non-motor phenotypes that has recently become a cutting edge field that directs frontier research
Parkinson's disease (PD) is a neurodegenerative disease with a 200 year-long research history. ...Autonom
Epidemiology of Parkinson's disease.
de Lau LM, Breteler MM. de Lau LM, et al. Lancet Neurol. 2006 Jun;5(6):525-35. doi: 10.1016/S1474-4422(06)70471-9. Lancet Neurol. 2006. PMID: 16713924 Review.
The causes of Parkinson's disease (PD), the second most common neurodegenerative disorder, are still largely unknown. ...In this article, we review what is known about the prevalence, incidence, risk factors, and prognosis of PD from epidemiolog …
The causes of Parkinson's disease (PD), the second most common neurodegenerative disorder, are still largely unk …
89,217 results
You have reached the last available page of results. Please see the User Guide for more information.